Spironolactone
The active substance of the medicine, spironolactone, reduces excess fluid in the body by increasing urine production. Spironolactone differs from other diuretic medicines in that it does not cause potassium loss in the urine. The medicine is used to treat:
Your doctor may have prescribed this medicine for a condition other than those listed in this leaflet. Children should only be treated under the supervision of a pediatrician.
Before starting to take Finospir, discuss it with your doctor or pharmacist.
Taking Finospir with certain medicines, potassium supplements, or potassium-rich foods may lead to severe hyperkalemia (high potassium levels in the blood). Symptoms of severe hyperkalemia may include muscle cramps, heart rhythm disturbances, diarrhea, nausea, dizziness, or headache. You should also tell your doctor about all other diseases and allergies. If surgery is required If surgery is required during Finospir treatment, tell your doctor about the medicine you are taking.
Finospir should be used with caution in children with high blood pressure, who have mild kidney failure, due to the risk of hyperkalemia (high potassium levels in the blood). Finospir should not be used in children with moderate or severe kidney failure (see "When not to take Finospir").
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or plan to take. Taking some medicines at the same time may affect their effectiveness, the effectiveness of Finospir, or cause side effects. Tell your doctor if you are taking mitotane for the treatment of malignant adrenal tumors. This medicine should not be taken at the same time as mitotane. It is very important to inform your doctor if you are taking any of the following medicines:
A potassium-rich diet is not recommended due to the risk of hyperkalemia.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, ask your doctor or pharmacist for advice before taking this medicine.
When starting treatment or changing the dose, dizziness, fatigue, or other side effects may occur (see section 4). These symptoms may have a negative impact on the ability to drive and use machines. At the beginning of treatment and after dose increase, avoid driving and using machines until you know how the medicine affects you. If you are going on vacation or a trip, make sure you have enough medicine.
The tablets contain lactose (in the form of lactose monohydrate) in a dose of: 57 mg (25 mg tablet), 114 mg (50 mg tablet), and 228 mg (100 mg tablet). If you have been diagnosed with intolerance to some sugars, contact your doctor before taking the medicine.
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist. The daily dose can be taken once or divided into two doses. Swallow the tablet with a glass of water or other liquid. Take the tablets with food. Remember that the medicine is better absorbed when taken during a meal. To maintain a constant effect, take the tablets at the same time every day. Taking the medicine at the same time is also the best way to remember to take it. The dose of Finospir is determined individually, depending on the disease and the patient's overall health. The following are the usual doses of the medicine. During treatment, your doctor will regularly check the levels of various chemicals (e.g., electrolytes and creatinine) in your blood.
Severe heart failure:The usual initial dose is 25 mg per day. Your doctor may decide to increase the dose to 50 mg per day or decrease it to 25 mg every other day. High blood pressure and swelling:The usual dose is 25 mg to 100 mg per day. Severe swelling:200 mg to 400 mg per day for a short time. Treatment of excessive aldosterone production (hormone produced by the adrenal glands):100 mg to 400 mg per day before surgery. Your doctor will determine the dose individually for each patient, prescribing the smallest effective dose when surgical treatment is not indicated.
There is usually no need to change the dose, unless the patient has kidney or liver failure.
Your doctor will determine the dose of the medicine based on the child's body weight and the type of disease. The tablet can be divided into equal doses.
When determining the dose, your doctor will take into account the patient's kidney function. Finospir should not be used in patients with severe kidney failure.
If you or someone else has taken a larger dose of the medicine than recommended, contact your doctor or hospital immediately. Overdose may cause the following symptoms: fatigue, confusion, mood changes, vomiting, dizziness, skin rash, and diarrhea. If you go to see a doctor or go to the hospital, take the medicine packaging with you.
If you miss a dose, take it as soon as possible. If it is almost time for the next dose, do not take the missed dose. Do not take a double dose or two consecutive doses to make up for the missed dose. Before going on vacation or a trip, make sure you have enough medicine. If you have any further questions about taking this medicine, ask your doctor or pharmacist.
Like all medicines, Finospir can cause side effects, although not everybody gets them. Side effects are more common in patients with poor health and multiple diseases. Neurological side effects, such as confusion, headaches, and loss of enthusiasm (apathy), occur mainly in patients with liver function disorders caused by long-term damage (liver cirrhosis). The following side effects are listed by frequency:
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people):
Frequency not known (frequency cannot be estimated from the available data):
If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181 C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: + 48 22 49 21 309, Website: https://smz.ezdrowie.gov.pl Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children. Do not use this medicine after the expiry date stated on the carton. The expiry date refers to the last day of the month. There are no special precautions for storing the medicine. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
25 mg tablets: white or almost white, round, flat tablets with beveled edges and a score line, 7 mm in diameter, with the code ORN85. 50 mg tablets: white or almost white, round, flat tablets with beveled edges and a score line, 9 mm in diameter, with the code ORN213. 100 mg tablets: white or almost white, round, slightly convex tablets with a score line, 11 mm in diameter, with the code ORN352. The tablet can be divided into equal doses. The tablets are packed in HDPE containers with HDPE closures. The packs contain: 25 mg: 30, 50, 100, and 250 tablets 50 mg and 100 mg: 30, 50, and 100 tablets PVC/Aluminum blisters 25 mg: 30 tablets 50 mg and 100 mg: 30 tablets Not all pack sizes may be marketed.
Orion Corporation Orionintie 1 FI-02200 Espoo Finland
Orion Corporation Orionintie 1 FI-02200 Espoo Finland Orion Corporation Orion Pharma Joensuunkatu 7 FI-24100 Salo Finland For more information about this medicine, contact the local representative of the marketing authorization holder: Orion Pharma Poland Sp. z o. o. kontakt@orionpharma.info.pl Date of last revision of the leaflet:07.2025
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.